Everything About Colonoscopy Has Improved. Except the Part You Do Yourself.

If you had a colonoscopy in 1985 and another one next week, the two procedures would be almost unrecognizable to each other.

The scope your physician uses today is a high-definition digital instrument that displays the colon on a bright screen in remarkable detail. In many practices, artificial intelligence now watches alongside the physician in real time, flagging small growths a human eye might pass over. The sedation is smoother and lighter, so most people wake up quickly and clearheaded. And the quality of the exam itself is now measured, tracked, and held to national benchmarks, because the field decided that "good enough" was not good enough.

Nearly every part of the colonoscopy has been rethought, refined, and modernized. Except one.

The part you do yourself, the night before, at home, is essentially the same as it was more than forty years ago.

Where the prep came from

The modern era of bowel preparation began in 1980. That year, a team of researchers led by Dr. John Fordtran developed a polyethylene glycol solution that could clean the colon without dangerously disrupting the body's fluids and salts. It was a genuine breakthrough for its time, and it replaced older regimens that were even harder on patients. The product became widely known by its brand name, and it quickly became the standard.

It also asked a lot of the patient. The original approach required drinking roughly four liters of a salty, unpleasant solution at home over a short window. That basic request, drink a large volume of laxative and manage the consequences on your own, has defined the experience ever since.

In the decades that followed, there were real efforts to make it easier. Lower-volume formulations arrived. Flavors improved. One popular low-volume option in the 1990s later drew an FDA safety warning over kidney risks and fell out of favor. And clinicians learned that splitting the dose, half the night before and half the morning of the procedure, produced cleaner results. That split-dose method is now the recommended standard, and it genuinely helped.

But step back and look at the shape of it. Every one of those changes is a refinement of the same basic idea. Smaller volume, better taste, better timing. The patient is still at home, alone, drinking a laxative and hoping they are doing it right. The delivery model never actually changed. It just got tuned.

There is a quiet irony in the timing. The generation born in 1980, the year this preparation was developed, is reaching screening age right now. Someone born that year is in their mid-forties today, which is exactly when colorectal cancer screening begins. Their very first colonoscopy will rely on the same preparation that existed on the day they were born. An entire generation has grown up. The prep waiting for them has not.

A modern procedure resting on a decades-old step

Here is why this matters, and it is not simply about comfort.

The entire value of a colonoscopy depends on the physician being able to see the colon wall clearly. Every advance of the last forty years, the high-definition optics, the AI assistance, the careful quality metrics, exists to help the physician find small, early, treatable growths. But none of that technology can do its job if the colon is not clean. The most sophisticated camera in medicine cannot see through what an incomplete prep leaves behind.

So the pathway has an unusual structure. The most advanced, most measured, most technologically current part of the process depends entirely on its oldest and least controlled step. And that step is handed to the patient to perform, unsupervised, the night before, with no way to know whether it worked until they are already on the table.

When it falls short, and across real-world practice a meaningful share of preparations do, the consequences ripple outward. Growths can be missed. Procedures run long. Patients are told to come back and do the whole thing again. A pathway engineered for precision is undermined at its very first step.

It is a strange thing to accept. In almost no other part of modern medicine would we take a procedure this important and leave its most decisive input to an unsupervised process designed in 1980.

Why the prep got left behind

The honest answer is that the prep was never really seen as part of the procedure. It happened offstage, at the patient's house, before anyone in the clinic was involved. The scope was where the medicine happened, so the scope is where the innovation went. The prep was treated as a chore to hand off rather than a clinical step to improve.

For a long time, that framing held. But the data has made it harder to defend. When a large share of people either avoid colonoscopy because of the prep or arrive with a preparation too incomplete to give a clear exam, the prep is no longer a minor preliminary. It is a decisive part of whether the screening works at all.

The step that got left behind turns out to be the step that quietly determines the outcome.

Modernizing the step that time forgot

This is the gap Zera Medical was built to close.

The company started from a simple observation. If every other part of the colonoscopy pathway earned a serious upgrade over the past four decades, the preparation deserves one too. Not another adjustment to the same at-home formula, but a genuine rethinking of where and how the prep happens.

That means treating preparation as a real clinical step, one that belongs in the care setting rather than being outsourced to the patient's bathroom at midnight. It means bringing the same standards of consistency, supervision, and dignity to the prep that the rest of modern medicine already brings to the procedure. The goal is straightforward: make the first step as reliable as everything that follows it.

The colonoscopy has come a long way since 1980. It is time the preparation did too.

If you are due for screening, the most important step is still the first one: talk to your doctor and get it on the calendar. The tools to catch this disease early are better than they have ever been. They work best when everyone can get through the door.

This post is part of an ongoing series from Zera Medical on the colorectal cancer screening gap and the preparation experience that shapes it. Zera Medical is developing ZeraFlow, a clinic-based bowel preparation system. ZeraFlow™ has not been cleared by the FDA and is not available for commercial use or sale in the United States. This device is currently under review for FDA clearance and is not available in all markets.